Clinical, laboratory, and radiographic assessments

Area of Science:

• Rheumatology
• Health Outcomes Research
• Clinical Trial Methodology

Background:

• Health-status instruments are crucial for evaluating rheumatic diseases.
• Existing measures require updates to capture comprehensive patient impact.
• The Medical Outcomes Study 36-Item Short Form Health Survey is a versatile tool for various illnesses.

Purpose of the Study:

• To introduce and evaluate Version 2 of the Arthritis Impact Measurement Scale (AIMS2).
• To assess the utility of AIMS2 and the Medical Outcomes Study 36-Item Short Form Health Survey for rheumatic conditions.
• To provide data on reliability and validity for osteoarthritis and ankylosing spondylitis assessment.

Main Methods:

• Evaluation of the revised Arthritis Impact Measurement Scale (AIMS2) Version 2.
• Review of health-status measures for osteoarthritis and ankylosing spondylitis.
• Analysis of reliability, sensitivity to change, sample size, and clinically significant change data.

Main Results:

• AIMS2 Version 2 includes enhanced items on work, satisfaction, and self-prioritized improvement areas.
• The Medical Outcomes Study 36-Item Short Form Health Survey is applicable across all illnesses, including rheumatic diseases.
• Comprehensive data on measure evaluation for osteoarthritis and ankylosing spondylitis were provided.

Conclusions:

• AIMS2 Version 2 and the Medical Outcomes Study 36-Item Short Form Health Survey are state-of-the-art health-status instruments.
• These tools offer invaluable resources for clinical trials and patient care in rheumatology.
• The provided data support the use of these measures for assessing disease impact and treatment effectiveness.